ArticleMolecular therapy. Methods & clinical development2020

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates.

Benjamin J Samelson-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.